Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome

NCT02617095 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

64

Enrollment

INDUSTRY

Sponsor class

Stopped recruitment rate too slow

Conditions

Dry Eye Syndrome

Interventions

DEVICE: T2762
DEVICE: Optive

Sponsor

Laboratoires Thea